EP0252974B1 - Erhöhung von enzymatischer wirksamkeit bei der reinigung von kontaktlinsen durch verwendung von hypotonischen lösungen - Google Patents

Erhöhung von enzymatischer wirksamkeit bei der reinigung von kontaktlinsen durch verwendung von hypotonischen lösungen Download PDF

Info

Publication number
EP0252974B1
EP0252974B1 EP87900942A EP87900942A EP0252974B1 EP 0252974 B1 EP0252974 B1 EP 0252974B1 EP 87900942 A EP87900942 A EP 87900942A EP 87900942 A EP87900942 A EP 87900942A EP 0252974 B1 EP0252974 B1 EP 0252974B1
Authority
EP
European Patent Office
Prior art keywords
enzyme
solution
contact lenses
cleaning
lenses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP87900942A
Other languages
English (en)
French (fr)
Other versions
EP0252974A1 (de
EP0252974A4 (de
Inventor
Stanley W. Huth
Sam W. Lam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Surgical Vision Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Priority to AT87900942T priority Critical patent/ATE83179T1/de
Publication of EP0252974A1 publication Critical patent/EP0252974A1/de
Publication of EP0252974A4 publication Critical patent/EP0252974A4/de
Application granted granted Critical
Publication of EP0252974B1 publication Critical patent/EP0252974B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005—Other compounding ingredients characterised by their effect
    • C11D3/0078—Compositions for cleaning contact lenses, spectacles or lenses
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38618—Protease or amylase in liquid compositions only

Definitions

  • This invention relates to the potentiation of the enzymatic activity in cleaning contact lenses. More specifically, this invention is a method for potentiating the proteolytic activity of the proteases pancreatin and subtilisin in the cleaning of contact lenses by carrying out the cleaning in a hypotonic solution.
  • Contact lenses particularly those with a hydrophilic surface such as the hydrogel lenses and the hard, gas permeable lenses with a treated surface, encounter protein accretions during normal wear. It is beneficial, if not often times necessary, to remove these accretions in order to maintain visual acuity, prevent eye irritation and to prevent the development of giant papillary conjunctivitis.
  • proteolytic enzymes has been developed to remove such deposits. See, for example, U.S. Patent 3,910,296, and 4,285,738.
  • the '296 disclosure makes no comment on the effect of tonicity value on enzyme activity.
  • the '738 patent discloses in the specification and stipulates in the claim, that the solution must be hypertonic. Hypertonic is not specifically defined, but the urea concentration is specified as being between 5% through saturation (weight/volume).
  • the normal tonicity value is that of a physiological solution as illustrated by the 0.9% by weight/volume concentration of aqueous saline.
  • This invention covers a method for enhancing the activity of an enzyme used in the cleaning of contact lenses, said enzyme being pancreatin or subtilisin, which method comprises carrying out the cleaning regimen in a solution having an osmolality value up to about 275 milliosmoles/kilogram.
  • Tonicity values may range from 0 up to about 275 mOsm/kg.
  • the enzyme itself will be active at tonicity values close to 0, but as a practical matter it is difficult to prepare such solutions because of the solutes normally present in diluents, including purified water. Tests have been carried out where the osmolality was as low as 6 mOsm/kg. A more preferred lower limit is about 50 mOsm/kg. which number allows for the addition of small amounts of salts, stabilizers, enzyme co-factors or other excipients which may be useful and beneficial to solution stability, enzyme activity or the like.
  • the upper limit will be between 175 and 200 mOsm/kg.
  • tonicity value can be made with any number of excipients and constituents well known in the art. If an enzyme co-factor is critical or essential to the cleaning process, obviously its presence must be given primary consideration in adding materials to the formulation. Salts of any sort including salts which are necessary co-factors for enzymatic activity such as calcium should be accounted for in formulating these hypotonic solutions. The hypotonic value is determined, that is measured, after addition of the enzyme.
  • the ability of a given solution and enzyme to remove protein from a contact lens was determined by essentially the same procedure each time. Generically, the procedure was to take a contact lens and coat it with heat denatured lysozyme by placing the lens in a phosphate buffered saline solution to which was then added sufficient lysozyme to make a 0.1% solution by weight. The lysozyme was from egg white. These solutions were then heated for 30 minutes at about 95 C. The lenses were removed, cooled and rinsed with distilled water and viewed to determine what type of lysozyme accretion was on the lens at time zero.
  • Protein deposit classification as a means for quantifying the proteolytic activity of enzymes in removing absorbed protein from the lenses, a system was developed whereby the protein on the lenses was visually quantified before and after enzyme treatment.
  • the lens After a lens had been heated for 30 minutes in the lysozyme solution, the lens was wetted with distilled water, rubbed between the thumb and finger, then grasped by the edge with plastic tweezers and rinsed with distilled water again. The convex side of the lens was viewed under a microscope at 100X magnification. A film or deposit detected under these conditions was classified according to the percentage of the lens surface covered by the deposit. The protein removal efficacy of an enzyme solution is expressed in terms of the percentage of the lens surface which has been cleaned. This number is derived by subtracting the percentage of the lens surface covered by the protein deposit from 100%.
  • a subtilisin enzyme containing solution was prepared as follows: cysteine hydrochloride monohydrate (1.001g), sodium borate dihydrate (1.911 g), sodium carbonate anhydrous (3.106g), polyethylene glycol 3350 (0.403g), tartaric acid (2.002g), S .
  • carlsberg (0.041g), obtained from Novo Industries of Denmark, was dissolved in 300 ml of purified water, the pH adjusted to 8.4 with sodium hydroxide or hydrochloric acid, and then water added in a quantity sufficient to make 1000 ml. Three 200 ml portions were removed and the osmolality adjusted with sodium chloride and the pH with NaOH or HCl as needed to obtain the figures given in table I.
  • Hydrogel-type lenses (Hydrocurve II®, 55% water, sold by Barnes-Hind, Inc.) were treated with heat-denatured lysozyme as described above.
  • a subtilisin-A-containing solution was prepared (0.04 mg/ml of water without excipients, activity: 0.0012 Au/ml) in such a manner as to have pH values between approximately 5.0 and 10.0.
  • the osmolality value was then adjusted to 6, 133 and 264 mOsm/kg with NaCl for each of these solutions, each of the tonicity values being tested at pH 9.0.
  • Lenses were then soaked in these solutions (five in each) for 2 hours at room temperature, rinsed, and analyzed for percentage residual protein deposit as described above. Results are given in Table II. Table II Effect of pH vs.
  • Lenses with lysozyme protein deposits covering at least 98% of the lens surface were cut in half, one half being soaked in one enzyme solution and the other in another enzyme solution in the first comparison (pancreatin data); whole lenses were used in the other studies.
  • the enzyme solutions were comprised of enzyme and excipients as indicated in Table III.
  • Lenses were bufilcon-A sold by Barnes-Hind, Inc. under the name Hydrocurve II®. Results from each of the several formulations are listed in the following table. The abbreviation DI is used for deionized water.
  • a subtilisin enzyme tablet was dissolved in either 10ml of DI water or saline. Each enzyme tablet contained: 30mg N-acetylcysteine, 34mg sodium carbonate, 7mg tartaric acid, 4mg polyethylene glycol 3350, 4mg subtilisin-A (subtilisin carlsberg from NOVO Industries of Denmark), and 50mg of lactose. 5. Allergan HydrocareTM Preserved Saline. It can be seen from the data presented in Table III that for both pancreatin and Subtilisin carlsberg , the solutions with the lowest tonicity produced the highest cleaning efficacy.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Detergent Compositions (AREA)
  • Eyeglasses (AREA)

Claims (2)

  1. Eine Methode zur Verbesserung der Aktivität eines zur Reinigung von Kontaktlinsen verwendeten, aus Pankreatin und Subtilisin ausgewählten Enzyms, welche die Durchführung der Reinigungsroutine in einer Lösung mit einem Osmolalitätswert bis zu 275 mOsm/kg umfaßt.
  2. Die in Anspruch 1 beschriebene Methode, wobei die Osmolalität zwischen 100 und 200 mOsm/kg beträgt.
EP87900942A 1986-01-06 1987-01-05 Erhöhung von enzymatischer wirksamkeit bei der reinigung von kontaktlinsen durch verwendung von hypotonischen lösungen Expired - Lifetime EP0252974B1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT87900942T ATE83179T1 (de) 1986-01-06 1987-01-05 Erhoehung von enzymatischer wirksamkeit bei der reinigung von kontaktlinsen durch verwendung von hypotonischen loesungen.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81651886A 1986-01-06 1986-01-06
US816518 1986-01-06

Publications (3)

Publication Number Publication Date
EP0252974A1 EP0252974A1 (de) 1988-01-20
EP0252974A4 EP0252974A4 (de) 1988-05-03
EP0252974B1 true EP0252974B1 (de) 1992-12-09

Family

ID=25220860

Family Applications (1)

Application Number Title Priority Date Filing Date
EP87900942A Expired - Lifetime EP0252974B1 (de) 1986-01-06 1987-01-05 Erhöhung von enzymatischer wirksamkeit bei der reinigung von kontaktlinsen durch verwendung von hypotonischen lösungen

Country Status (6)

Country Link
EP (1) EP0252974B1 (de)
AT (1) ATE83179T1 (de)
AU (1) AU6898887A (de)
DE (1) DE3782981T2 (de)
HK (1) HK113995A (de)
WO (1) WO1987004091A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037647A (en) * 1988-09-15 1991-08-06 Alcon Laboratories, Inc. Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride
CA2009118C (en) * 1989-02-21 1996-02-27 Mary F. Mowrey-Mckee Method and composition for cleaning and disinfecting contact lenses
US5783532A (en) * 1993-06-17 1998-07-21 Allergan Enzyme compositions and methods for contact lens cleaning
IL109705A (en) * 1993-06-17 1998-07-15 Allergan Inc Enzyme compositions and methods for contact lens cleaning

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3240709A (en) * 1962-05-16 1966-03-15 Burton Parsons Chemicals Inc Method of cleansing contact lenses
US3910296A (en) * 1973-04-20 1975-10-07 Allergan Pharma Method of removing proteinaceous deposits from contact lenses
US4048122A (en) * 1976-01-23 1977-09-13 Barnes-Hind Pharmaceuticals, Inc. Cleaning agents for contact lenses
JPS54140553A (en) * 1978-04-24 1979-10-31 Senju Pharma Co Contact lens washing liquid
US4263054A (en) * 1979-02-23 1981-04-21 George D. Weaver Contact lens cleaning and rinsing method
GB2088581A (en) * 1980-10-02 1982-06-09 Smith & Nephew Associated Cie Papain and lactose containing tablet for cleaning contact lenses
US4521254A (en) * 1981-02-09 1985-06-04 Anderson Ronald L Cleaning contact lenses with solution of bromelain and carboxypeptidase
GB2117534B (en) * 1982-03-31 1986-02-19 Smith & Nephew Ass Papain containing tablet for cleaning contact lenses
US4626292A (en) * 1982-06-01 1986-12-02 Sherman Laboratories, Inc. Soft contact lens wetting and preservation method
US4613380A (en) * 1985-04-01 1986-09-23 Dow Corning Corporation Method for removing lipid deposits from contact lenses
US4670178A (en) * 1985-09-09 1987-06-02 Allergan Pharmaceuticals, Inc. Method for the simultaneous cleaning and disinfecting of contact lenses

Also Published As

Publication number Publication date
EP0252974A1 (de) 1988-01-20
EP0252974A4 (de) 1988-05-03
ATE83179T1 (de) 1992-12-15
HK113995A (en) 1995-07-21
WO1987004091A1 (en) 1987-07-16
DE3782981D1 (de) 1993-01-21
AU6898887A (en) 1987-07-28
DE3782981T2 (de) 1993-04-08

Similar Documents

Publication Publication Date Title
EP0772669B1 (de) Salzlösung zur behandlung von kontaktlinsen
US5356555A (en) Non-oxidative method and composition for simultaneously cleaning and disinfecting contact lenses using a protease with a disinfectant
US5718895A (en) Enzymes with low isoelectric points for use in contact lens cleaning
US20050282715A1 (en) Use of multifunctional surface active agents to clean contact lenses
RU2126273C1 (ru) Способ разложения перекиси водорода (варианты), способ дезинфекции контактных линз (варианты), способ дезинфекции контактной линзы, состав таблетки для разложения перекиси водорода, композиция (варианты)
KR100253435B1 (ko) 안정한 액체 효소 조성물, 및 콘택트 렌즈 세정및 소독 시스템에서 이 조성물을 사용하는 방법
JPH07168145A (ja) コンタクトレンズの洗浄消毒用製剤
US20060241001A1 (en) Composition for treating contact lenses
US4521254A (en) Cleaning contact lenses with solution of bromelain and carboxypeptidase
US6136850A (en) Methods and compositions for inhibiting deposit formation on contact lenses
EP0252974B1 (de) Erhöhung von enzymatischer wirksamkeit bei der reinigung von kontaktlinsen durch verwendung von hypotonischen lösungen
EP0426489A2 (de) Zusammensetzungen zur Zersetzung von Wasserstoffperoxid und Verfahren zu deren Verwendung
KR100263147B1 (ko) 콘텍트렌즈용제제의안정화방법
US20030133905A1 (en) Composition for treating contact lenses in the eye
US6214596B1 (en) Liquid enzyme compositions and methods of use in contact lens cleaning and disinfecting systems
CA1265079A (en) Enhancement of enzymatic activity in cleaning contact lenses by use of hypotonic solutions
US5328846A (en) Method for removing exogenous deposits from hydrophilic contact lenses
JPH09263795A (ja) コンタクトレンズ用洗浄溶液及びそれを用いたコンタクトレンズの洗浄処理方法
US5209783A (en) Method for simultaneously cleaning, decolorizing and thermally disinfecting contact lenses
US6273960B1 (en) Method of cleaning contact lenses using carbon dioxide and carbonic acid
WO1985003247A1 (en) Method for cleaning contact lenses
JP3552838B2 (ja) コンタクトレンズ溶液及びそれを用いた洗浄消毒方法
Kim et al. Protease Activities in Various Kinds of Enzymatic Cleaners for Contact Lenses
Kim et al. Protease Activities in Various Kinds of Enzymatic Cleaneers for Contact Lenses
JPH04296714A (ja) コンタクトレンズの洗浄、脱色および加熱消毒を同時に行なう方法

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19871026

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19880503

17Q First examination report despatched

Effective date: 19890420

ITTA It: last paid annual fee
GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

REF Corresponds to:

Ref document number: 83179

Country of ref document: AT

Date of ref document: 19921215

Kind code of ref document: T

ET Fr: translation filed
REF Corresponds to:

Ref document number: 3782981

Country of ref document: DE

Date of ref document: 19930121

ITF It: translation for a ep patent filed

Owner name: BARZANO' E ZANARDO MILANO S.P.A.

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
EPTA Lu: last paid annual fee
EAL Se: european patent in force in sweden

Ref document number: 87900942.1

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 19971222

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 19980108

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: LU

Payment date: 19980109

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 19980115

Year of fee payment: 12

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19990105

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19990105

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19990131

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19990131

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19990131

BERE Be: lapsed

Owner name: ALLERGAN INC.

Effective date: 19990131

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20030131

Year of fee payment: 17

NLS Nl: assignments of ep-patents

Owner name: ADVANCED MEDICAL OPTICS, INC.

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040803

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20041216

Year of fee payment: 19

REG Reference to a national code

Ref country code: FR

Ref legal event code: TP

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20041229

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20050117

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20050120

Year of fee payment: 19

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060105

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060106

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060131

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20060131

Year of fee payment: 20

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060801

EUG Se: european patent has lapsed
GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20060105

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20060801

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20060929